Tokorozawa, Japan

Masami Murayama

This inventor holds 1 USPTO granted patent. Top assignee: Terumo Kabushiki Kaisha. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masami Murayama. Retrieved from https://idiyas.com/inventor/masami-murayama-z48603t4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masami Murayama: Inventor of a Blood-Glucose Measurement Device.

Introduction

Masami Murayama is an inventor associated with Tokorozawa, Japan, and Terumo Kabushiki Kaisha. Her patent work includes a device designed to measure blood components using reflected light and test paper.

Latest Patents

Murayama is credited with 1 patent, titled “Component Measurement Device.” The invention describes a blood-glucose measurement device with a measurement unit that directs measurement light through an illumination lens onto test paper and detects the light reflected from it. The device determines blood-component measurements from the detection results. Its illumination lens is arranged so that the measurement light’s focal point lies beyond the test paper.

Career Highlights

Murayama’s listed patent connects her work with optical measurement technology for blood-glucose testing. The patent record identifies Terumo Kabushiki Kaisha as her company.

Collaborations

Her listed coworkers include Eiki Izumi and Takashi Morita.

Conclusion

Masami Murayama’s patent describes an optical approach to measuring blood components, with a lens arrangement designed to focus measurement light beyond the test paper.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…